Cargando…
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy
A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobul...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995714/ https://www.ncbi.nlm.nih.gov/pubmed/29321424 http://dx.doi.org/10.2169/internalmedicine.9466-17 |
_version_ | 1783330651768881152 |
---|---|
author | Deguchi, Kentaro Matsuzono, Kosuke Nakano, Yumiko Kono, Syoichiro Sato, Kota Deguchi, Shoko Tanabe, Katsuyuki Hishikawa, Nozomi Ota, Yasuyuki Yamashita, Toru Ohta, Kiyoe Motomura, Masakatsu Abe, Koji |
author_facet | Deguchi, Kentaro Matsuzono, Kosuke Nakano, Yumiko Kono, Syoichiro Sato, Kota Deguchi, Shoko Tanabe, Katsuyuki Hishikawa, Nozomi Ota, Yasuyuki Yamashita, Toru Ohta, Kiyoe Motomura, Masakatsu Abe, Koji |
author_sort | Deguchi, Kentaro |
collection | PubMed |
description | A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobulin were ineffective. He then displayed repeated exacerbations and remissions over the course of two years, despite two to four sessions of plasma exchange (PE) every two months. The patient was successfully treated with outpatient periodic weekly blood purification therapy with alternative PE and double-filtration plasmapheresis using an internal shunt. This case report suggests the benefits of blood purification therapy with an internal shunt against anti-MuSK antibody-positive MG. |
format | Online Article Text |
id | pubmed-5995714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-59957142018-06-13 Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy Deguchi, Kentaro Matsuzono, Kosuke Nakano, Yumiko Kono, Syoichiro Sato, Kota Deguchi, Shoko Tanabe, Katsuyuki Hishikawa, Nozomi Ota, Yasuyuki Yamashita, Toru Ohta, Kiyoe Motomura, Masakatsu Abe, Koji Intern Med Case Report A 37-year-old man with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG) presented with subacute progressive dysphagia and muscle weakness of the neck and bilateral upper extremities. Conventional immune-suppressive treatments and high-dose intravenous immunoglobulin were ineffective. He then displayed repeated exacerbations and remissions over the course of two years, despite two to four sessions of plasma exchange (PE) every two months. The patient was successfully treated with outpatient periodic weekly blood purification therapy with alternative PE and double-filtration plasmapheresis using an internal shunt. This case report suggests the benefits of blood purification therapy with an internal shunt against anti-MuSK antibody-positive MG. The Japanese Society of Internal Medicine 2018-01-11 2018-05-15 /pmc/articles/PMC5995714/ /pubmed/29321424 http://dx.doi.org/10.2169/internalmedicine.9466-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Deguchi, Kentaro Matsuzono, Kosuke Nakano, Yumiko Kono, Syoichiro Sato, Kota Deguchi, Shoko Tanabe, Katsuyuki Hishikawa, Nozomi Ota, Yasuyuki Yamashita, Toru Ohta, Kiyoe Motomura, Masakatsu Abe, Koji Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title | Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title_full | Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title_fullStr | Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title_full_unstemmed | Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title_short | Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy |
title_sort | anti-musk antibody-positive myasthenia gravis successfully treated with outpatient periodic weekly blood purification therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995714/ https://www.ncbi.nlm.nih.gov/pubmed/29321424 http://dx.doi.org/10.2169/internalmedicine.9466-17 |
work_keys_str_mv | AT deguchikentaro antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT matsuzonokosuke antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT nakanoyumiko antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT konosyoichiro antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT satokota antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT deguchishoko antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT tanabekatsuyuki antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT hishikawanozomi antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT otayasuyuki antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT yamashitatoru antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT ohtakiyoe antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT motomuramasakatsu antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy AT abekoji antimuskantibodypositivemyastheniagravissuccessfullytreatedwithoutpatientperiodicweeklybloodpurificationtherapy |